20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T13076 | Tamoxifen-d5 | ICI 47699-d5,(Z)-Tamoxifen-d5,trans-Tamoxifen-d5 | HSP |
Tamoxifen-d5 is a deuterium labeled Tamoxifen. Tamoxifen is a selective modulator of estrogen receptor (SERM). Tamoxifen is a potent activator of Hsp90 and enhances the Hsp90 molecular chaperone ATPase activity. | |||
T28919 | Tamoxifen analog II | Tamoxifen analog III | |
Tamoxifen analog II is a potent growth inhibitor. Tamoxifen analog II displays activity against various cancer cell lines. | |||
T22512 | 4’-hydroxy Tamoxifen | Others | |
It is a metabolite of tamoxifen and an estrogen receptor modulator. | |||
T4420 | 4-Hydroxytamoxifen | ICI 79280,(Z)-4-hydroxy Tamoxifen,trans-4-Hydroxytamoxifen | Estrogen Receptor/ERR , Estrogen/progestogen Receptor |
4-Hydroxytamoxifen (ICI 79280) is the active metabolite of Tamoxifen, an estrogen receptor modulator (SERM) with selective and oral potency. 4-Hydroxytamoxifen has antitumor activity and may be used in breast cancer rese... | |||
T4281 | Endoxifen | (E/Z)-N-desmethyl-4-hydroxy Tamoxifen,(E/Z)-Endoxifen | Estrogen Receptor/ERR , Aromatase , Estrogen/progestogen Receptor , Parasite , Drug Metabolite |
(E/Z)-Endoxifen ((E/Z)-Endoxifen) is an active metabolite of tamoxifen produced by the sequential action of cytochrome P450 (CYP) isoforms, including CYP2D6. It is a strong anti-estrogen, as it has an approximately 100-f... | |||
T31262 | Deamino-hydroxytamoxifen | Tamoxifen-ol,Tamoxifen metabolite Y | |
Tamoxifen is a medication that is used to prevent breast cancer patients. | |||
T19192 | α-Hydroxytamoxifen | α-OHTAM,(E)-α-Hydroxy tamoxifen | Others |
α-Hydroxytamoxifen is a metabolite of tamoxifen. It reacts with DNA and causes the formation of DNA adducts. | |||
T8984 | FLTX1 | Estrogen Receptor/ERR , Estrogen/progestogen Receptor | |
FLTX1 is a fluorescent derivative of Tamoxifen, designed to efficiently target and label intracellular Tamoxifen-binding sites (estrogen receptors) both under permeabilized and non-permeabilized conditions. Additionally,... | |||
T12148 | N-Desmethyltamoxifen hydrochloride | Estrogen Receptor/ERR , Endogenous Metabolite , PKC | |
N-Desmethyltamoxifen hydrochloride is the major tamoxifen metabolite in humans. | |||
T6743 | (E/Z)-4-Hydroxytamoxifen | Afimoxifene,4-Hydroxytamoxifen | Estrogen Receptor/ERR , Estrogen/progestogen Receptor |
(E/Z)-4-Hydroxytamoxifen (Afimoxifene) is the active metabolite of tamoxifen and a selective estrogen receptor (ER) modulator that is widely used in the therapeutic and chemopreventive treatment of breast cancer. | |||
T12148L | N-Desmethyltamoxifen | Others | |
N-Desmethyltamoxifen, the principal metabolite of tamoxifen in humans, serves as an efficacious modulator of ceramide metabolism within human AML cells by inhibiting ceramide glycosylation, hydrolysis, and sphingosine ph... | |||
T15186 | (E)-4-Hydroxytamoxifen | Others | |
(E)-4-Hydroxytamoxifen is a less active isomer of (Z)-4-hydroxytamoxifen and also is an estrogen receptor modulator. | |||
T2280 | Endoxifen (Z-isomer) | Endoxifen Z-isomer | Estrogen Receptor/ERR , EGFR , Potassium Channel , Estrogen/progestogen Receptor , HER |
Endoxifen Z-isomer (EDX) is a key active metabolite of tamoxifen (TAM) with higher affinity and specificity to estrogen receptors that also inhibits aromatase activity. | |||
T15249 | Estrogen receptor modulator 1 | Estrogen Receptor/ERR | |
Estrogen receptor modulator 1 causes regression of Tamoxifen-resistant, hormone-independent xenograft tumors. Estrogen receptor modulator 1 is an orally active and selective estrogen receptor modulator (SERM) (pIC50: 0.4... | |||
T6827L | Endoxifen hydrochloride | ||
Endoxifen hydrochloride, a principal active metabolite of Tamoxifen (TAM), exhibits heightened affinity and specificity towards the estrogen receptor and possesses aromatase inhibitory capability. It holds promise for br... | |||
T11098 | Droloxifene | 3-Hydroxytamoxifen | Estrogen Receptor/ERR |
Droloxifene (3-Hydroxytamoxifen), a tamoxifen derivative, is an oral active and selective estrogen receptor modulator.Droloxifene induced p53 expression and apoptosis in McF-7 cells.Fluroxifene has anti-estrogen and anti... | |||
T3855 | Tracheloside | Estrogen Receptor/ERR , Phosphorylase | |
Tracheloside significantly decreases the activity of alkaline phosphatase (IC50: 0.31 μg/ml), a level of inhibition comparable to that of tamoxifen (IC50: 0.43 μg/ml). | |||
T35973 | Cholesterol-5α,6α-epoxide | Epoxycholesterol,5α,6α-epoxy Cholestanol,NSC 18176 | Others |
Cholesterol-5α,6α-epoxide (Epoxycholesterol) is the metabolite of cholesterol produced by oxidation. Cholesterol-5α,6α-epoxide induces triacylglycerol biosynthesis by binding to LXRβ following tamoxifen and PBPE applicat... | |||
T34326 | Ridaifen-B | RidaifenB | |
Ridaifen-B, a tamoxifen derivative, works by inducing independent autophagy of Bcl-2, without estrogen receptor involvement. | |||
T71578 | Endoxifen mesylate | ||
Endoxifen, also known as N-desmethyl-4-hydroxytamoxifen, is a chemical that is under development for estrogen receptor-positive breast cancer. It is also being evaluated as an antipsychotic for treatment of mania and ot... |